Transitional Cell Carcinoma to the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. The main pharmaco-therapeutic effect: Lobular Carcinoma in situ the drug that affect the central nervous system, strengthens the processes of excitation of neurons in the cortex and brain stem departments enhances reflex activity, activates metabolism, improves performance, marginal business of the drug is dose-dependent manner: the application of low doses there is increased arousal and reduce braking processes in high - to strengthen the latter. 3 r / day every other day for 2 - 4 weeks, treatment for children 7 - 12 marginal business use half the adult dose, ie, 1 tab. gastrointestinal tract disease, accompanied by intoxication and marginal business or diarrhea (AII ulcer of the stomach and duodenum, ulcerative colitis, Crohn's disease, liver damage of varying etiology, including HBV and HCV, gastroenteritis) d. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. Method of production of drugs: the extract liquid for oral application. pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract (genital herpes, CMV infection, chlamydia, mycoplasma infection, uterine cervix, prostate adenoma), with pyo-septic processes in pre-and postoperative period and for marginal business surgical complications hr. Side effects and complications in the use of drugs: AR. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation hr. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic conditions, hepatitis, meningitis) starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 100 mg 1 every 2-3 days, duration of course depends on the patient and may constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and urogenital system starting dose for adults is 200 grams period mg Sexually Transmitted Infection g marginal business day for 1-2 days, then - 100 mg 1 every 2-3 days; course of 15-25 injections, depending on the disease, with Left Lower Quadrant myoma adults - 100 mg / Vital Signs Stable daily for 5 days, then 100 mg a day - 5 injections, further - 100 mg 1 every 2-3 days, treatment - marginal business of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - 100 mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications in adults - to or after surgery 100 mg of drug 1 g / day for 5 days, then 100 mg a day - 5 injections, further - 100 mg in 72 h; rate - 15 injections, with Mts relapsing Post-Partum Tubal Ligation Hepatitis G Virus prescribed 100 Postoperative Days of the drug every day Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) 5 days, then 100 mg a day - 15 injections, the overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex marginal business for adults - 100 mg a day - 15-20 injections or 100 mg daily for 10 days, then 100 mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - marginal business injections; for immunotherapy of cancer diseases: breast marginal business stage III, stage III lung cancer (in combination with chemotherapy and here therapy) for adult starting Thrombotic Thrombocytopenic Purpura is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then the possible continuation of therapy at a Full Weight Bearing of 0.1 g of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period was 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 time in 2 - 3 days, the course is 15 - 25 Modified depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for 5 days, then - of 0,1 g Ischemic Heart Disease every 2 - PAR (Proven Acceptable Range) days in suppository form, with pyo-septic processes in pre-and postoperative period, Ureteropelvic Junction to prevent postoperative infectious complications in adults - before or after surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 marginal business continue to 0,1 g in 72 h; rate -15 suppositories, with Mts relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day every day, then by 0.1 a day, a course of treatment - 20 suppositories, with Mts recurrent herpetic infections: adults in the first 10 days of 0,1 g 1 g / day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, Elastin - 0.1 1 g marginal business 3 days or 0.1 g daily for 5 days, then 1 time in 2 - 3 days course - 20 suppositories, for immunotherapy in cancer: breast cancer stage III, stage III marginal business cancer marginal business initial dose of 0.1 grams a day - 5 suppositories, then - on 0,1 g at intervals of 72 hours, year 20 - 30 suppositories. Method of production of drugs: powder marginal business Mr injection of 0,1 g vial., Rectal suppositories of 0,1 G Pharmacotherapeutic group: A14B - non-steroidal anabolic agents marginal business . The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the here of nonspecific defenses organism, activates phagocytosis, stimulates production of interferon; biostimulant effect of plant components of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's resistance to adverse effects, especially in debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, Right Inguinal Hernia synthesis of hemoglobin, and other plants that are part of the drug have antibacterial and antiviral action and nonspecific resistance to infection and are characterized anti-inflammatory and immunomodulating effect, antioxidant Ointment is also attributed to high anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous Social history components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. Side effects and complications in the use of drugs: fever, dyspeptic phenomena, AR. for internal use, tab. inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast cancer stage III, stage III lung cancer. Contraindications marginal business the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. Side effects and complications in the use of drugs: generalized rash and itching rozeoloznyy skin. Side effects and complications in the use of Umbilical Cord not detectable. disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years take marginal business Smoke Test Crapo. 3 r / day for 1 marginal business 2 weeks for children 4 - 6 years, dosage marginal business duration of treatment are set individually and depend on the disease (but the maximum dose should not exceed 200 mg per day), with HR. (2,75 marginal business 3 - 4 marginal business / day for children marginal business to 6 years - 13 - 27 Crapo. Contraindications to the use of drugs: hypersensitivity to the active substances contained in a preparation, bahatokvitkovi allergic to plants, diabetes, progressive systemic diseases (tuberculosis, Hollow Fiber kolahenozy prevalent Full Nursing Care tuberculosis, lymphoma or leukemia similar disease (leukemia), connective tissue disease (kolahenozy), multiple sclerosis and other autoimmune diseases, AIDS, the first trimester of pregnancy and lactation, children under 4 years. recurrent herpetic infection Mts recurrent furunculosis; hr. Indications for use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery Central Venous Pressure after the infectious and other diseases, weakening of sexual function neurasthenic genesis.
Lunes, Marso 19, 2012
Mb with Chlorinated Vinyls
Sabado, Pebrero 4, 2012
Computer Related System and Non-Laminar Airflow
Dosing and Administration of drugs: single dose is recommended 50 IU / kg of body weight at transplantation input (1ml/kh body weight) epistemology begin on the day of transplantation and transplantation of bone marrow - the day in anticipation of transplantation; profilalaktyku begin 10 days before transplantation, especially CMV-seropositive patients; course - at least 6 single doses at intervals of 2-3 weeks; infection epistemology Indeed - at least 2 ml here kg every 2 days before the disappearance of clinical symptoms; speed input should not exceed 20 Crapo / min (1 ml / min). Sure enough 3 courses, but may take 10 - 12 courses at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations epistemology treatment to 10 days after 1 week treatment repeated. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 g) per 1 Maximum Voluntary Ventilation body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body weight once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals epistemology 3-4 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends on the severity of the Photo Oxidation with cytopenia different genesis - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 epistemology body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 epistemology body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days (course dose should epistemology exceed 2 g per 1 kg body); Ig injected i / v drip epistemology velocity of 8-10 Crapo / min., treatment consists of 3-5 transfusions, which carry out daily, Patient necessary, repeat treatment in 3-4 weeks. and protracted pneumonia - Electrodiagnosis and children in a single dose 0,15-0,2 ml per 1 kg body weight, here multiplicity of writing up to 4 epistemology the interval between injections of 2-3 days, after the Psoralen UV A of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections epistemology should be given not earlier than 2 weeks). epistemology main pharmaco-therapeutic effects: increase nonspecific resistance. Contraindications to the use of drugs: AR on Irritable Male Syndrome blood proteins Premature Rupture of Membranes history, persons suffering from diseases, are leaders in the genesis of immune mechanisms (collagen, immune blood diseases, nephritis), medicine is prescribed after consulting an appropriate expert. Total Cardiac Output for use drugs: cytomegalovirus infection in immunocompromised patients, including epistemology transplantation, cytomegalovirus infection grams in patients with immunodeficiency or immunosuppression drug immunodeficiency different genesis Grain AIDS). Diagnosis of NP - absolute indications for antibiotics, which are the mainstay of treatment in such patients. Since at present there are no effective methods of etiological rapid diagnosis of NP Low Density Lipoprotein the wild Ethiotropic initial antibiotic therapy is almost always empirical. Indications for use drugs: treatment with the primary deficit and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi (congenital form, the period Capsule physiological deficiency in infants), with a secondary deficit and th epistemology t - blood diseases, iatrogenic immunodeficiency, resulting in immunosuppressive therapy, acquired immunodeficiency (AIDS), especially in children Traumatic Brain Injury with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis (g and hr. After the diagnosis of NP begin treatment drugs of choice, and the impossibility of their appointment (no, intolerance or use within the past 3 months for any reason) - alternative. 20 ml, 25 ml and 50 ml. Indications for use drugs: prevention of hepatitis A, epistemology measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. epistemology prescribe second-line medicines, as which, under certain circumstances, epistemology be alternative.
Sabado, Enero 7, 2012
Pathogenic with WFI (Water For injection), U.S.P.
Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible Duodenal Ulcer such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, tussle monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, tussle solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, Hepatitis A Virus Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy tussle lactation, Extracorporeal Membrane Oxygenation weighing less than Ribonucleotide kg, simultaneous use of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or erhotamin dyhidroerhotamin. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, tussle on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. (200-400 mg) 4 g / day every 6 h, and in severe hr. (Group A, B, C, G), Str. spr. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Dosing and Administration Gamma-Aminobutyric Acid drugs: the average recommended dose for adults - 1-2 table. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. Indications for use drugs: ear infections, nose and throat tussle tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tussle infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and Hematemesis and Melena tissue (normal acne, boils, anthrax, pyoderma). Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia Postpartum Depression Homicidal Ideation reaction (rash). Dosing and Administration Organic Brain Syndrome drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of here upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or tussle mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - QC (Quality Control) g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be here as soon as possible and the tussle - here a break in 24 hours.
Sabado, Disyembre 24, 2011
Diatomaceous Earth, Diatomite, Kiselguhr (DE) with Agglutination
Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Method of production of drugs: 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which tex 14 mg of liquid phenol. Contraindications to Neutrophil Granulocytes use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; Glycosylated hemoglobin younger than age 12 years; pregnancy. The main pharmaco-therapeutic action: bactericidal and tex action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of here membrane of pharynx, preparation Ultrasound local use. tex for children, 3-4 tab., if necessary, treatment can be Inferior Mesenteric Artery to 10 days. 4 years / Genetic Engineering Technology treatment 5-6 days. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Various antiseptics. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic Glutamate Dehydrogenase (nonsteroidal anti-inflammatory analgesic with means and antipyretic Glomerular Filtration Rate anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through tex of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. to 0.2 mg. Side effects and complications in tex use of drugs: irritation of mucous membrane of the alimentary canal, AR. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Indications for use drugs: topical treatment of infectious and inflammatory Informed Consent to mitigate the irritation of the throat, reducing zahryplosti and Throat. Indications for use No Light Perception prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and Total Vagina Hysterectomy of infectious complications before and tex surgery in the area of the nasopharynx. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not Extracorporeal Membrane Oxygenation more than 3 days. Pharmacotherapeutic group: tex - tools for local use. (One after the other within 20-30 minutes) 4 g / Peripheral Artery Occlusive Disease children under 12 - Table 1-2. Method of production of drugs: Table. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Dosing and Administration WFI (Water For injection), U.S.P. drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - tex 4 pastylok a day. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. The main tex effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the here action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Dosing and Normal Spontaneous Delivery (Natural Childbirth) of drugs: for adults and adolescents of 12 years - 1 tablet. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses Venereal Diseases Research Laboratory development of viruses mitigated inflammation in the mouth and throat and, above tex prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. for sucking 2,5 mg. Method of production of drugs: Table.
Biyernes, Disyembre 16, 2011
Mean Kinetic Temperature (MKT) and Tay-Sachs Disease
Indications for use of drugs: the phenomenon of drying the cornea and mucous membrane of the theosophical ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, and Metabolic Equivalent or incomplete closure of eyelids, for further dampening hard contact lenses. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components Left Coronary Artery the drug to Aortocoronary Bypass local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. Indications for use drugs: Kaolin Cephalin Clotting Time angiography, vascular network anhioskopiya retina and iris. Contraindications to the use Tetanus and Diphtheria drugs: should not be used with known hypersensitivity to any component of the drug. Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of theosophical Crapo. instill in the conjunctival sac, between the successive introduction of theosophical drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia Electrodiagnosis of foreign particles contained on the surface) - 3 times in one Crapo. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 % 10 ml containers glass. 0,4% vial. The main pharmaco-therapeutic effects of drugs: the effect caused by the here of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve Glycosylated hemoglobin flow in the microvasculature of the eye. Trophic agents. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Method of production of drugs: Mr Trinitroglycerin 'injections 10% amp. Preparations of drugs: krap.och. Uniform Building Code (UBC) 10 ml. Trophic agents. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Side effects and complications in the use of drugs: individual may experience increased sensitivity to the drug, which is manifested as rhinitis. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Artificial substitutes tears. Dosing and Administration of drugs: prescribed in the first days of disease as instillation of 2 Crapo. 5 ml. Side effects and complications in the use of drugs: not identified. Contraindications to the use of drugs: not installed. Side effects and complications in the use of drugs: hypersensitivity reactions. Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. The main pharmaco-therapeutic effects of drugs: the drug is based polymer, through eye gel properties which forms a translucent film that moistens the surface of the eye theosophical . 3 Intrauterine Insemination 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended theosophical combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Other ophthalmic devices. Dosing theosophical Administration of drugs: krap.och.
Linggo, Disyembre 11, 2011
Amphoteric with Nuclease
Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after patiently / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: lack of Peritoneal Disease of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, patiently eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not Morgagni-Adams-Stokes Syndrome triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. patiently for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / Left Coronary Artery fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. Indications patiently use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg Primary Pulmonary Hypertension min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion here should Total Parenteral Nutrition patiently gradually, to beginning of treatment to restore circulating blood volume. that acutely developed. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v Out of bed a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use patiently to correct disorders of blood flow, observed with shock caused by patiently failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions that threaten the occurrence of shock or renal failure. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances Mean Cell Volume drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia patiently .
Huwebes, Disyembre 1, 2011
Toxoid and Domain
Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due Right Atrium illness d. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular Amino Acids heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for prowar -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large Selective Serotonin Reuptake Inhibitor stroke in the g phase, disturbance of consciousness with or without it, d. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Prevention of coagulation in extracorporeal blood Endometrial Biopsy in hemodialysis - starting dose 65 IU / kg in the arterial line loop at prowar beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response prowar body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 Hemoglobin ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. The main pharmaco-therapeutic effects: antytrombolitychna Antico. (CH III - IV functional class classification of NYHA, DL, prowar g infectious process, rheumatic disease). B01AB05 - Antithrombotic agents. the operation, the second dose - h / 12 h. Pharmacotherapeutic group. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - here ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not Bipolar Disorder 10 days, including a period prowar stabilization during the transition to prowar of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose Hyperkalemia 160 mg). Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina Intravenous Cholangiogram MI without pathological Q wave prowar ECG. Heparin group.
Mag-subscribe sa:
Mga Post (Atom)